FDA Guidance for Industry: Considerations in Demonstrating Interchangeability With a Reference Product
Title:
FDA Guidance for Industry: Considerations in Demonstrating Interchangeability With a Reference Product
Origin/Publisher:
FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM537135.pdf
Content:
This guidance is intended to assist sponsors in demonstrating that a proposed therapeutic protein product is interchangeable with a reference product for the purposes of submitting a marketing application or supplement under section 351(k) of the Public Health Service Act (PHS Act) (42 U.S.C. 262(k)).